Holen Sie sich die Stockscreener-App
2.99
1.01%
0.03
Handel nachbörslich:
3.02
0.03
+1.00%
Schlusskurs vom Vortag:
$2.96
Offen:
$2.97
24-Stunden-Volumen:
40,087
Relative Volume:
0.77
Marktkapitalisierung:
$41.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.87M
KGV:
-1.8777
EPS:
-1.5924
Netto-Cashflow:
$-21.21M
1W Leistung:
-1.32%
1M Leistung:
-6.56%
6M Leistung:
+70.86%
1J Leistung:
-14.81%
1-Tages-Spanne:
$2.96
$3.03
1-Wochen-Bereich:
$2.96
$3.14
52-Wochen-Spanne:
$1.42
$4.22
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Vergleichen Sie CALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
2.99 | 41.36M | 0 | -20.87M | -21.21M | -1.5924 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
Will CalciMedica Inc. stock pay special dividendsTrade Volume Report & Technical Entry and Exit Tips - newser.com
Best data tools to analyze CalciMedica Inc. stock2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
Why CalciMedica Inc. stock remains on buy listsWeekly Profit Report & Weekly Breakout Opportunity Watchlist - newser.com
Is CalciMedica Inc. stock near bottom after declineQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com
Should I hold or sell CalciMedica Inc. stock in 2025Market Sentiment Review & Weekly Consistent Profit Watchlists - newser.com
Can CalciMedica Inc. recover in the next quarter2025 Stock Rankings & Consistent Profit Alerts - newser.com
Using data filters to optimize entry into CalciMedica Inc.2025 AllTime Highs & Verified Short-Term Plans - newser.com
Analyzing drawdowns of CalciMedica Inc. with statistical toolsJuly 2025 Market Mood & AI Powered Market Entry Strategies - newser.com
How to build a custom watchlist for CalciMedica Inc.M&A Rumor & Growth Oriented Trade Recommendations - newser.com
Is CalciMedica Inc. stock reversal real or fakeFed Meeting & Weekly High Return Stock Forecasts - newser.com
What MACD and RSI say about CalciMedica Inc.July 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Tools to monitor CalciMedica Inc. recovery probability2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com
Is CalciMedica Inc. still worth holding after the dipGold Moves & AI Enhanced Trading Signals - newser.com
Analyzing CalciMedica Inc. with risk reward ratio chartsJuly 2025 Pullbacks & Detailed Earnings Play Strategies - newser.com
Comparing CalciMedica Inc. in custom built stock radars2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Detecting support and resistance levels for CalciMedica Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Technical signs of recovery in CalciMedica Inc.Quarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
Regression analysis insights on CalciMedica Inc. performanceJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
What recovery options are there for CalciMedica Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Is CalciMedica Inc. stock bottoming outTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-01 11:57:05 - newser.com
CalciMedica and Telperian team up for Auxora trial analysis - MSN
Calcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment - MSN
Analyzing net buyer seller activity in CalciMedica Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):